Peripheral Nerve Stimulation to Reduce Hypoxic Events

November 13, 2018 updated by: Hugh M. Smith, Mayo Clinic

A Randomized Control Trial of the Oxistimulator as an Adjunct to Standard Practice to Decrease Extent and Duration of Oxygen Desaturation in Adult Patients Who Have Received Anesthetics or Are Receiving Sedating Medications

This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.

Study Overview

Detailed Description

The primary effectiveness objective is to determine if transcutaneous stimulation will generate a respiratory response capable of reducing the extent and duration of oxygen desaturations in patients with presumed risk of obstructive sleep apnea (OSA) who have received some form of anesthesia or sedation. The primary safety objective is the demonstration that the peripheral nerve stimulation is safe for the use of preventing or reducing the sedation related hypoxemic events.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria

  • Males and females > 18 yrs old
  • Flemon's Score > 15
  • Able to provide written informed consent
  • Having gynecological, colorectal, orthopedic surgery, and urologic surgeries
  • Baseline oxygen saturation on room air > 96%

Exclusion Criteria:

  • Peripheral neuropathy involving the upper extremities
  • Procedures requiring direct admission to the ICU or any site other than the post-anesthesia care unit from the OR
  • Diagnosed obstructive sleep apnea (OSA) and / or use of continuous positive airway pressure (CPAP) or biphasic positive airway pressure (BiPAP) in the PACU.
  • Presence of any implantable electric devices, including internal defibrillators, pacemakers, or left ventricular assist device (LVAD)
  • Post-procedure temperature < 35.5 Celsius or evidence of vasoconstriction
  • Presence of metal hardware in either arm or in either shoulder
  • Patients lacking access to the bare skin on an arm after surgery.
  • History of atrial fibrillation
  • History of bundle branch block
  • Females from menarche to menopause that do not have a current negative pregnancy test or surgical history preventing pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stimulator Active Device
Intervention: This intervention arm will use a Stimulator Active Device peripheral nerve stimulation. Participants will receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
This is a stimulator active device that delivers peripheral nerve stimulation in conjunction with pulse oximetry information.
Sham Comparator: Stimulator Sham Device
No intervention: This arm will use a Stimulator Sham Device peripheral nerve stimulation.Participants will not receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
This is an stimulator sham device that is not providing peripheral nerve stimulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Area Under the Curve for oxygen saturation (SpO2%)
Time Frame: One hour
One hour

Secondary Outcome Measures

Outcome Measure
Time Frame
Frequency of desaturation episodes
Time Frame: One hour
One hour
Frequency of nursing interventions
Time Frame: One hour
One hour
Frequency of Adverse Events
Time Frame: 72 hours
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Hugh Smith, MD, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2015

Primary Completion (Actual)

January 19, 2017

Study Completion (Actual)

January 19, 2017

Study Registration Dates

First Submitted

September 17, 2015

First Submitted That Met QC Criteria

September 17, 2015

First Posted (Estimate)

September 18, 2015

Study Record Updates

Last Update Posted (Actual)

November 15, 2018

Last Update Submitted That Met QC Criteria

November 13, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Apnea

Clinical Trials on Stimulator active device

Subscribe